Latest ABG-WTT Global Life Science Capital Partners GP Lt Stock Portfolio

About ABG-WTT Global Life Science Capital Partners GP Lt and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ABG-WTT Global Life Science Capital Partners GP Ltd reported an equity portfolio of $43.7 Millions as of 31 Dec, 2024.

The top stock holdings of ABG-WTT Global Life Science Capital Partners GP Ltd are , , RPID. The fund has invested 64.4% of it's portfolio in CERIBELL INC and 32.5% of portfolio in CG ONCOLOGY INC.

ABG-WTT Global Life Science Capital Partners GP Ltd opened new stock positions in CERIBELL INC.

New Buys

Ticker	$ Bought
ceribell inc	28,160,100

New stocks bought by ABG-WTT Global Life Science Capital Partners GP Lt

Additions

No additions were made to existing positions by ABG-WTT Global Life Science Capital Partners GP Lt

Reductions

None of the existing positions were reduced by ABG-WTT Global Life Science Capital Partners GP Lt

Sold off

None of the stocks were completely sold off by ABG-WTT Global Life Science Capital Partners GP Lt

ABG-WTT Global Life Science Capital Partners GP Lt Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ABG-WTT Global Life Science Capital Partners GP Lt

Last Reported on: 14 Feb, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
LUNG	pulmonx corp	0.94	60,204	408,785	unchanged	0.00

RPID	rapid micro biosystems inc	2.14	1,038,300	934,466	unchanged	0.00

	ceribell inc	64.42	1,088,100	28,160,100	new

	cg oncology inc	32.51	495,526	14,211,700	unchanged	0.00